像罗氏，默克之类的制药巨擎，为数组技术还应用于药物开发过程。
Drugs giants such as Roche and Merck are also routinely using microarrays in their drug-discovery processes.
罗氏理论的另一优势在于理论是建立在对人的研究之上的(而非实验室里的小动物)，这使得其在生活的多个领域都具有很强的应用价值。
Another strength is that Rogerian theory is grounded in the study of persons (not pigeons), leading to its strong applied value in many areas of life.
三月份，罗氏和生物基因艾迪克就研究中的新发现向美国食品药品监督管理局(Food and Drug Administration)提出新应用的申请。
In March, Roche and Biogen Idec filed an application with the U.S. Food and Drug Administration seeking expanded approval of Rituxan as reflected in the study's findings.
应用推荐